RCDTF
Price:
$58
Market Cap:
$10.62B
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally. It operates through Specialty and Primary Care; and Rare Diseases segments. The company develops Maapliv for maple syrup urine disease; Isturia for endogenous Cushing's syndrome; Cystadrops treatment of the ocular manifestations of cystinosis; Carbaglu for hyperammonemia due to n-acetyl glutamate synthase deficiency; Qarziba for neuroblastoma patients and patients with relapsed or refractory neuroblastoma; and Fotivda for renal cell...[Read more]
Industry
Medical - Pharmaceuticals
IPO Date
2010-12-17
Stock Exchange
OTC
Ticker
RCDTF
According to Recordati S.p.A.’s latest financial reports and current stock price. The company's current PE Ratio is 16.60. This represents a change of -21.02% compared to the average of 21.02 of the last 4 quarters.
The mean historical PE Ratio of Recordati S.p.A. over the last ten years is 24.59. The current 16.60 PE Ratio has changed 6.65% with respect to the historical average. Over the past ten years (40 quarters), RCDTF's PE Ratio was at its highest in in the June 2022 quarter at 38.44. The PE Ratio was at its lowest in in the March 2023 quarter at 16.23.
Average
24.59
Median
25.27
Minimum
19.62
Maximum
30.21
Discovering the peaks and valleys of Recordati S.p.A. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 25.54%
Maximum Annual PE Ratio = 30.21
Minimum Annual Increase = -26.36%
Minimum Annual PE Ratio = 19.62
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 22.47 | -10.29% |
| 2024 | 25.05 | -3.38% |
| 2023 | 25.93 | 1.70% |
| 2022 | 25.49 | -15.62% |
| 2021 | 30.21 | 15.31% |
| 2020 | 26.20 | 25.54% |
| 2019 | 20.87 | 6.38% |
| 2018 | 19.62 | -26.36% |
| 2017 | 26.64 | 13.82% |
| 2016 | 23.41 | -5.74% |
The current PE Ratio of Recordati S.p.A. (RCDTF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
24.48
5-year avg
25.83
10-year avg
24.59
Recordati S.p.A.’s PE Ratio is less than CSPC Pharmaceutical Group Limited (21.18), greater than Grifols, S.A. (15.24), less than Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (17.39), less than Orion Oyj (19.63), less than Bangkok Dusit Medical Services Public Company Limited (20.00), greater than Grifols, S.A. (15.24), less than CSPC Pharmaceutical Group Limited (21.18), less than Swedish Orphan Biovitrum AB (publ) (111.03), less than Bangkok Dusit Medical Services Public Company Limited (20.00), greater than Kyowa Kirin Co., Ltd. (15.80),
| Company | PE Ratio | Market cap |
|---|---|---|
| 21.18 | $12.13B | |
| 15.24 | $8.00B | |
| 17.39 | $5.82B | |
| 19.63 | $11.66B | |
| 20.00 | $8.90B | |
| 15.24 | $8.70B | |
| 21.18 | $12.20B | |
| 111.03 | $16.74B | |
| 20.00 | $10.17B | |
| 15.80 | $7.55B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Recordati S.p.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Recordati S.p.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Recordati S.p.A.'s PE Ratio?
How is the PE Ratio calculated for Recordati S.p.A. (RCDTF)?
What is the highest PE Ratio for Recordati S.p.A. (RCDTF)?
What is the 3-year average PE Ratio for Recordati S.p.A. (RCDTF)?
What is the 5-year average PE Ratio for Recordati S.p.A. (RCDTF)?
How does the current PE Ratio for Recordati S.p.A. (RCDTF) compare to its historical average?